Skip to content
value.today

Avalon Globocare Corp.

🇺🇸 Freehold, New Jersey, USAHealth CareFounded 2014

Formerly Global Technologies Corp.

Total raised
$9 M
2 rounds on record
Latest round
$5 M
Oct 2017
First round on record
Dec 2016
Today
Went public
See the company page

Avalon Globocare Corp. is listed today as Change Agents Corporation.: market value, financials and filings are on its company page.

Funding rounds

2 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Avalon Globocare Corp.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2026$3 MPrivate placement after listing$2 to $10 million

Avalon Globocare Corp.: Private sale, Feb 2026

Investors in this round

2 investors had bought by the notice of Mar 12, 2026: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$227,500
Finders' fees
none
Paid to its own people
$552,500 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Luisa Ingargiola · Executive Officer · Chief Financial Officer
  • Meng Li · Executive Officer · Interim Chief Executive Officer and Chief Operating Officer
  • Lourdes Felix · Director
  • Michael A. Mathews · Director
  • Steven A. Sanders · Director
  • Wenzhao Lu · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • H.C. Wainwright & Co., LLC (CRD 000000375) · New York, New YorkSold in IL, NY

Remarks in the notice

  • On fees: “Excludes 1% non-accountables; 1% management fees; 7% on the exercise price paid in cash for warrants; $50,000 of accountable expenses; and five-year warrants to purchase 318,628 shares of common stock at $0.6375 per share.”

Signed by Luisa Ingargiola, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 12, 2026. Read the notice at the SEC.

equity, optionsSEC
Oct 2017$5 MNo. 2$2 to $10 million

Avalon Globocare Corp.: Raise no. 2, Oct 2017

Investors in this round

1 investor had bought by the notice of Dec 19, 2017.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$1,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$400,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Jin · Executive Officer, Director · CEO, President and Director
  • Luisa J Ingargiola · Executive Officer · CFO
  • Meng J Li · Executive Officer, Director · COO, Secretary and Director
  • Steven J Sukel · Director
  • Wenzhao J Lu · Director · Chairman and Director
  • Wilbert J Tauzin II · Director · Director
  • Yancen J Lu · Director · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The proceeds will be used for M&A activity and for general corporate purposes, including, but not limited to, employee/cons”

Signed by David Jin, Chief Executive Officer, President and Director. Source: SEC Form D, newest notice filed Dec 19, 2017. Read the notice at the SEC.

equitySEC
Dec 2016$4 MNo. 1$2 to $10 million

Avalon Globocare Corp.: Raise no. 1, Dec 2016

Investors in this round

27 investors had bought by the notice of Dec 21, 2016: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered; $0 M still to sell
Smallest investment taken
$1,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Jin · Executive Officer, Director · CEO, President and Director
  • Meng Li · Executive Officer, Director · Director and COO
  • Wenzhao Lu · Director · Chairman

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Working capital.”

Signed by David Jin, Chief Executive Officer, President and Director. Source: SEC Form D, newest notice filed Dec 21, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Avalon Globocare Corp. chose not to state its revenue in its newest notice of a funding round (Mar 2026).

    SEC Form D · Mar 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Mar 2026

That is all the official record says: Avalon Globocare Corp. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Avalon Globocare Corp. are on record.

Investors#

No investor of Avalon Globocare Corp. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 27 investors.

Largest shareholders today

Institutions holding Change Agents Corporation. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Avalon Globocare Corp.
NameRoleNamed in
Luisa IngargiolaChief Financial OfficerMar 2026
Meng LiInterim Chief Executive Officer and Chief Operating OfficerMar 2026
David JinCEO, President and DirectorDec 2017
Luisa J IngargiolaCFODec 2017
Meng J LiCOO, Secretary and DirectorDec 2017
Lourdes FelixDirectorMar 2026
Michael A. MathewsDirectorMar 2026
Steven A. SandersDirectorMar 2026
Wenzhao LuDirectorMar 2026
David JinCEO, President and DirectorDec 2017
Meng J LiCOO, Secretary and DirectorDec 2017
Steven J SukelDirectorDec 2017
Wenzhao J LuChairman and DirectorDec 2017
Wilbert J Tauzin IIDirectorDec 2017
Yancen J LuDirectorDec 2017
Meng LiDirector and COODec 2016

Went public since 2017. Its SEC number is that of a company listed on a stock exchange.